Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSE:STN - Stantec Stock Price, Forecast & News

$29.92
+0.11 (+0.37 %)
(As of 01/22/2020 01:30 AM ET)
Today's Range
$29.62
Now: $29.92
$30.03
50-Day Range
$26.25
MA: $28.30
$29.92
52-Week Range
$20.22
Now: $29.92
$30.03
Volume53,374 shs
Average Volume66,506 shs
Market Capitalization$3.33 billion
P/E Ratio31.83
Dividend Yield1.48%
Beta1.27
Stantec Inc provides professional consulting services in the area of infrastructure and facilities for clients in the public and private sectors in Canada, the United States, and internationally. It operates through three segments: Consulting Services - Canada, Consulting Services - United States, and Consulting Services - Global. The company offers consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management and planning, and project economics. Read More…

Industry, Sector and Symbol

Industry Engineering services
Sub-IndustryN/A
SectorBusiness Services
CUSIPN/A
Phone780-917-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.31 billion
Cash Flow$1.43 per share
Book Value$13.16 per share

Profitability

Net Income$36.57 million

Miscellaneous

Employees22,000
Market Cap$3.33 billion
Next Earnings Date2/27/2020 (Estimated)
OptionableNot Optionable

Receive STN News and Ratings via Email

Sign-up to receive the latest news and ratings for STN and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

A U.S. congressional committee passed important legislation that enables each state to set its own policies around cannabis… This bill also allows states to expunge federal marijuana convictions and arrests. This will likely lead to federal legalization sooner than expected. Get in early and you just might be the next 'Marijuana Millionaire'...

Stantec (NYSE:STN) Frequently Asked Questions

What is Stantec's stock symbol?

Stantec trades on the New York Stock Exchange (NYSE) under the ticker symbol "STN."

How often does Stantec pay dividends? What is the dividend yield for Stantec?

Stantec declared a quarterly dividend on Wednesday, November 6th. Shareholders of record on Monday, December 30th will be given a dividend of $0.11 per share on Wednesday, January 15th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend is Friday, December 27th. View Stantec's Dividend History.

When did Stantec's stock split? How did Stantec's stock split work?

Stantec shares split on the morning of Monday, November 17th 2014. The 2-1 split was announced on Thursday, September 4th 2014. The newly issued shares were issued to shareholders after the closing bell on Friday, November 14th 2014. An investor that had 100 shares of Stantec stock prior to the split would have 200 shares after the split.

How were Stantec's earnings last quarter?

Stantec Inc. (NYSE:STN) issued its earnings results on Wednesday, November, 6th. The business services provider reported $0.44 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.42 by $0.02. The business services provider had revenue of $716.52 million for the quarter, compared to analyst estimates of $700.81 million. Stantec had a return on equity of 11.53% and a net margin of 2.99%. View Stantec's Earnings History.

When is Stantec's next earnings date?

Stantec is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Stantec.

What price target have analysts set for STN?

6 equities research analysts have issued 1-year price targets for Stantec's shares. Their forecasts range from $33.00 to $42.00. On average, they anticipate Stantec's share price to reach $37.92 in the next year. This suggests a possible upside of 26.7% from the stock's current price. View Analyst Price Targets for Stantec.

What is the consensus analysts' recommendation for Stantec?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stantec in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stantec.

Has Stantec been receiving favorable news coverage?

News coverage about STN stock has trended negative on Wednesday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Stantec earned a coverage optimism score of -2.2 on InfoTrie's scale. They also assigned news stories about the business services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Stantec.

Are investors shorting Stantec?

Stantec saw a drop in short interest in December. As of December 13th, there was short interest totalling 1,300,000 shares, a drop of 5.1% from the November 28th total of 1,370,000 shares. Based on an average daily volume of 53,500 shares, the days-to-cover ratio is presently 24.3 days. Approximately 1.2% of the shares of the company are sold short. View Stantec's Current Options Chain.

Who are some of Stantec's key competitors?

What other stocks do shareholders of Stantec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stantec investors own include TELUS (TU), PPL (PPL), AbbVie (ABBV), Energy Transfer LP Unit (ET), Verizon Communications (VZ), Canadian Natural Resources (CNQ), JPMorgan Chase & Co. (JPM), Occidental Petroleum (OXY), SM Energy (SM) and Toronto-Dominion Bank (TD).

Who are Stantec's key executives?

Stantec's management team includes the folowing people:
  • Mr. Gordon Allan Johnston, Pres, CEO & Director (Age 53)
  • Mr. Scott L. Murray, Exec. VP & COO
  • Mr. Valentino DiManno, Exec. VP & Chief Bus. Officer
  • Mr. Steve M. Fleck, Exec. VP and Chief Practice & Project Officer
  • Ms. Theresa B. Y. Jang, Exec. VP & CFO (Age 54)

Who are Stantec's major shareholders?

Stantec's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Zurcher Kantonalbank Zurich Cantonalbank (0.32%), Galibier Capital Management Ltd. (0.10%), CLARET ASSET MANAGEMENT Corp (0.05%) and Cardinal Capital Management Inc. (0.00%).

Which institutional investors are selling Stantec stock?

STN stock was sold by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank , Galibier Capital Management Ltd. and CLARET ASSET MANAGEMENT Corp.

Which institutional investors are buying Stantec stock?

STN stock was bought by a variety of institutional investors in the last quarter, including Cardinal Capital Management Inc..

How do I buy shares of Stantec?

Shares of STN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Stantec's stock price today?

One share of STN stock can currently be purchased for approximately $29.92.

How big of a company is Stantec?

Stantec has a market capitalization of $3.33 billion and generates $3.31 billion in revenue each year. The business services provider earns $36.57 million in net income (profit) each year or $1.40 on an earnings per share basis. Stantec employs 22,000 workers across the globe.View Additional Information About Stantec.

What is Stantec's official website?

The official website for Stantec is http://www.stantec.com/.

How can I contact Stantec?

Stantec's mailing address is 10220 103 AVENUE, EDMONTON A0, T5J 0K4. The business services provider can be reached via phone at 780-917-7000 or via email at [email protected]


MarketBeat Community Rating for Stantec (NYSE STN)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  314 (Vote Outperform)
Underperform Votes:  435 (Vote Underperform)
Total Votes:  749
MarketBeat's community ratings are surveys of what our community members think about Stantec and other stocks. Vote "Outperform" if you believe STN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel